Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
SHH
REST API REST API
Homo sapiens
SHH is differentially expressed in 156 experiments: 79 organism parts: bone marrow, liver, ... (77 more);, 116 disease states: normal, glioblastoma, ... (114 more);, 38 cell types 181 cell lines 19 compound treatments and 63 other conditions.
Synonyms SMMCI, HPE3, MCOPCB5, TPT, HHG1, TPTPS, HLP3
Orthologs shhb (Danio rerio)   Shh (Rattus norvegicus)   SHH (Bos taurus)   Shh (Mus musculus)   Q8MY57_CIOIN (Ciona intestinalis)   shha (Danio rerio)   SHH (Gallus gallus)   hh (Drosophila melanogaster)   shh (Xenopus laevis)   B8PZT0_CANFA (Canis familiaris)   (Compare orthologs)
Gene Ontology Term angiogenesis, hindgut morphogenesis, establishment of cell polarity, striated muscle tissue development, pattern specification process, plasma membrane, embryo development, androgen metabolic process, positive regulation of hh target transcription factor activity, neuroblast proliferation, endoplasmic reticulum, protein binding, apoptosis, regulation of transcription, DNA-dependent, digestive tract morphogenesis, negative regulation of proteasomal ubiquitin-dependent protein catabolic process, cell proliferation, regulation of cell proliferation, extracellular space, trachea morphogenesis, positive regulation of cell proliferation, positive regulation of gene expression, developmental growth, intein-mediated protein splicing, peptidase activity, negative regulation of apoptosis, Golgi apparatus, male genitalia development, embryonic foregut morphogenesis, embryonic morphogenesis, extracellular region, cell-cell signaling, blood coagulation, membrane raft, response to hypoxia, membrane fraction, cell fate specification, smoothened signaling pathway, ventral midline development, negative regulation of Wnt receptor signaling pathway, signal transducer activity, positive regulation of photoreceptor cell differentiation, positive regulation of neuroblast proliferation, cell communication, axon guidance, positive regulation of transcription from RNA polymerase II promoter, multicellular organismal development, nucleus, response to axon injury, heart development, negative regulation of cell migration, regulation of gene expression, positive regulation of smoothened signaling pathway, male genitalia morphogenesis, canonical Wnt receptor signaling pathway, patched binding, cell death, cell fate commitment, regulation of proteolysis, proteolysis, stem cell development, negative regulation of transcription from RNA polymerase II promoter, cell surface, negative regulation of cell differentiation, extracellular matrix, positive regulation of Wnt receptor signaling pathway, response to ethanol, determination of left/right symmetry, negative regulation of gene expression, ectoderm development, signal transduction, positive regulation of transcription, DNA-dependent, calcium ion binding, central nervous system development, zinc ion binding, regulation of apoptosis, dorsal/ventral pattern formation, endocytosis, positive regulation of oligodendrocyte progenitor proliferation, positive regulation of mesenchymal cell proliferation, embryonic organ development, right lung development, regulation of epithelial cell differentiation, neural tube formation, negative regulation of alpha-beta T cell differentiation, transport vesicle, prostate gland development, striated muscle cell differentiation, bud outgrowth involved in lung branching, lung lobe morphogenesis, oligodendrocyte differentiation, epithelial-mesenchymal signaling involved in prostate gland development, positive regulation of neuron differentiation, response to organic nitrogen, epithelial tube branching involved in lung morphogenesis, positive regulation of striated muscle cell differentiation, trachea development, regulation of epithelial cell proliferation involved in prostate gland development, mesenchymal cell proliferation, hair follicle development, regulation of prostatic bud formation, positive regulation of skeletal muscle tissue development, kidney development, branching involved in ureteric bud morphogenesis, hindbrain development, Bergmann glial cell differentiation, embryonic hindlimb morphogenesis, mesenchymal smoothened signaling pathway involved in prostate gland development, negative thymic T cell selection, prostate epithelial cord elongation, limb development, inner ear development, primary prostatic bud elongation, forebrain development, branching involved in salivary gland morphogenesis, myotube differentiation, sclerotome development, embryonic forelimb morphogenesis, lung-associated mesenchyme development, multicellular structure septum development, positive regulation of protein import into nucleus, epithelial-mesenchymal cell signaling, dorsal/ventral neural tube patterning, embryonic skeletal system development, hair follicle morphogenesis, ventral spinal cord interneuron specification, anatomical structure development, anatomical structure formation involved in morphogenesis, cellular response to lithium ion, branching morphogenesis of a tube, pancreas development, vasculogenesis, lymphoid progenitor cell differentiation, branching involved in prostate gland morphogenesis, positive regulation of alpha-beta T cell differentiation, myoblast differentiation, odontogenesis, metanephros development, limb bud formation, vasculature development, neural crest cell migration, response to retinoic acid, glycosaminoglycan binding, intermediate filament organization, positive regulation of oligodendrocyte differentiation, embryonic digit morphogenesis, embryonic digestive tract morphogenesis, left lung development, osteoblast development, artery development, positive regulation of cell differentiation, skin development, laminin-1 binding, lung morphogenesis, glycoprotein binding, digestive tract mesoderm development, response to estradiol stimulus, epithelial cell proliferation involved in salivary gland morphogenesis, lung development, tongue morphogenesis, positive regulation of epithelial cell proliferation involved in prostate gland development, camera-type eye development, patterning of blood vessels, neuron fate commitment, palate development, mesenchymal cell proliferation involved in lung development, telencephalon regionalization, oligodendrocyte development, respiratory tube development, thymus development, odontogenesis of dentine-containing tooth, salivary gland cavitation, thyroid gland development, embryonic limb morphogenesis, midbrain development, renal system development, negative regulation of canonical Wnt receptor signaling pathway, spinal cord dorsal/ventral patterning, heart looping, positive regulation of skeletal muscle cell proliferation, positive thymic T cell selection, formation of anatomical boundary, lung epithelium development, regulation of mesenchymal cell proliferation involved in prostate gland development, positive regulation of penile erection, negative regulation of T cell proliferation, cell development, negative regulation of protein catabolic process, organ formation, somite development, determination of left/right asymmetry in lateral mesoderm, T cell differentiation in thymus, protein localization to nucleus, CD4-positive or CD8-positive, alpha-beta T cell lineage commitment, positive regulation of immature T cell proliferation in thymus, positive regulation of kidney smooth muscle cell differentiation, negative regulation of ureter smooth muscle cell differentiation, negative regulation of transcription elongation from RNA polymerase II promoter, positive regulation of mesenchymal cell proliferation involved in ureter development, positive regulation of ureter smooth muscle cell differentiation, smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation, positive regulation of cerebellar granule cell precursor proliferation, metanephric mesenchymal cell proliferation involved in metanephros development, negative regulation of kidney smooth muscle cell differentiation, positive regulation of T cell differentiation in thymus, anterior/posterior pattern specification
InterPro Term Hedgehog_hint_N, Hedgehog_hint_C, Peptidase_C46, Peptidase_C46_hint, Intein_splice_site, Hedgehog_signaling_dom
UniProt Accession Q15465, C9JC48, D9ZGF9, F8WEH4, F8WB84
Gene-Disease Assocation SCHIZENCEPHALY, COLOBOMA, OCULAR, MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 5; MCOPCB5, SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI, HOLOPROSENCEPHALY 3; HPE3, POLYDACTYLY, PREAXIAL II; PPD2
Search EB-eye ENSG00000164690
Show more properties
Experimental Factors
Organism part

studied in E-AFMX-5, E-GEOD-803, E-GEOD-22541, E-MEXP-1251, E-MTAB-24, ... (18 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-5258, E-GEOD-22639, E-GEOD-19639, E-GEOD-18005, E-GEOD-24147, ... (21 experiments)

Factor Value U/D Experiments
MCF-10A
2
E-TABM-420, E-GEOD-14990
MCF-7
2
E-GEOD-20081, E-GEOD-5823
SW480
2
E-MEXP-1014, E-MTAB-37
H720
1
E-GEOD-3202
EB1
1
E-MTAB-37
KatoIII
1
E-GEOD-15460
175 more value(s).


Cell type

studied in E-MEXP-1121, E-GEOD-3920, E-GEOD-13987, E-GEOD-11755, E-GEOD-2822, ... (25 experiments)

Factor Value U/D Experiments
memory B cell
2
E-MEXP-2360, E-TABM-702
secretory cell
1
E-GEOD-3998
mononuclear cell
1
E-GEOD-6053
spermatocyte
1
E-TABM-130
hematopoietic stem cell
1
E-MEXP-872
fibroblast
1
E-GEOD-3920
32 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-6872, E-GEOD-15960, E-GEOD-2466, E-MEXP-1121, ... (33 experiments)

Factor Value U/D Experiments
glioblastoma
3
E-MTAB-62, E-GEOD-4412, E-GEOD-4290
lung adenocarcinoma
2
E-MTAB-37, E-GEOD-2514
hepatocellular carcinoma
1
E-MTAB-37
Kaposi's sarcoma
1
E-MEXP-561
control
1
E-GEOD-16363
carcinoma in situ lesion
1
E-GEOD-3167
110 more value(s).


Compound treatment

studied in E-GEOD-20719, E-GEOD-3284, E-GEOD-6907, E-GEOD-412, E-GEOD-3720, ... (10 experiments)

Factor Value U/D Experiments
none
3
E-GEOD-412, E-GEOD-20719, E-GEOD-6907
vanadium pentoxide
1
E-GEOD-5339
Cxcl12
1
1
E-GEOD-7307
1mM GDC-0941
1
1
E-GEOD-20719
phorbol 12-myristate 13-acetate + ionomycin
1
E-GEOD-3720
phoshate buffered saline
1
E-GEOD-3720
13 more value(s).


Age at diagnosis

studied in E-GEOD-21653

Factor Value U/D Experiments
29
1
1
E-GEOD-21653


Agent
studied in E-GEOD-19519

BioSourceProvider
studied in E-GEOD-19519

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

Cellular component
studied in E-GEOD-1400

Classifier
studied in E-GEOD-3493

Clinical history
studied in E-GEOD-19743, E-GEOD-7967, E-GEOD-21589, E-GEOD-16363, E-GEOD-1725 ... (5 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-19348, E-MEXP-1251, E-GEOD-21589, ... (6 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743, E-MTAB-62

Dfs follow up
studied in E-GEOD-22541

Disease free interval dfi in months
studied in E-GEOD-22541

Disease stage
studied in E-GEOD-7463

Disease staging
studied in E-GEOD-19743, E-GEOD-21138

Environmental stress
studied in E-GEOD-1643, E-GEOD-3720

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-7578, E-GEOD-6431

Genotype
studied in E-GEOD-22056, E-GEOD-2466, E-GEOD-22593, E-TABM-321, E-GEOD-18005, ... (6 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-MEXP-1446, E-GEOD-837

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-276, E-GEOD-20194, E-GEOD-16716, E-GEOD-2748

Individual
studied in E-MTAB-197, E-GEOD-2466, E-MEXP-2069, E-TABM-666, E-GEOD-19330, ... (24 experiments)

Infection
studied in E-GEOD-12108, E-MEXP-561, E-GEOD-980

Injury
studied in E-GEOD-19743

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-MEXP-455, E-GEOD-9171

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Nbefore
studied in E-GEOD-20194, E-GEOD-16716

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-7540, E-GEOD-1801, E-TABM-84

Performer
studied in E-LGCL-5

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-22309

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-3254, E-GEOD-19246

RNAi
studied in E-MEXP-101, E-GEOD-3697

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743

Sex
studied in E-GEOD-2466, E-GEOD-22541, E-GEOD-7307

Stimulation
studied in E-GEOD-11428

stimulus
studied in E-GEOD-22103

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-TABM-276, E-GEOD-2748

Treatment
studied in E-GEOD-22152, E-GEOD-16837, E-GEOD-19246, E-GEOD-15799

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-22541

Processing time: 0.363 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM